Biomax Informatics: Universities use NeuroXM™ to study the connectome in drug-resistant epilepsy
The NeuroXM Brain Science Suite of Biomax was used to develop a knowledge model for high-resolution intra-areal connectivity with more than 50,000 cortical nodes and several million connections, as well as corresponding automated processing pipelines. This connectivity network could then be visualized and accessed via the web portal of NICARA™, the neuroimaging solution offered by Biomax. "Our experience shows us that our software can be easily deployed in hospitals," explained project leader Dr. Markus Butz-Ostendorf of Biomax. "In addition, it can also be combined with other data from genetics or from other imaging approaches such as PET, CT or EEG."
Dr. Marcus Kaiser, Professor of Neuroinformatics at the University of Nottingham, confirms, "The use of NeuroXM and NICARA is central to this research project. With the help of this advanced neuroimaging solution, we can analyze and evaluate the changes in the local network within brain regions and thus assess whether surgery will be successful or not."
The results from this study have now been published in the journal Human Brain Mapping.
End of Press Release
Biomax provides computational solutions for better decision making and knowledge management in the life sciences. They help customers generate value by integrating information from proprietary and public resources to enable a knowledge-based approach to developing innovative life science products. Biomax’s worldwide customer community includes companies and research organizations that are successful in drug discovery, diagnostics, fine chemicals, food and plant production. More information is available at www.biomax.com.
Labvantage – Biomax GmbH
Robert-Koch-Str. 2
82152 Planegg
Telefon: +49 (89) 895574-0
Telefax: +49 (89) 895574-825
http://www.biomax.com
Senior Product Manager
Telefon: +49 (89) 895574-0
E-Mail: markus.butz-ostendorf@biomax.com
Marketing Manager
E-Mail: bettina.klitzing-stueckle@biomax.com